Inspire Medical Systems (INSP) Projected to Post Quarterly Earnings on Monday

Inspire Medical Systems (NYSE:INSP) is expected to be issuing its quarterly earnings data after the market closes on Monday, February 10th. Analysts expect the company to announce earnings of $0.74 per share and revenue of $239.76 million for the quarter. Parties interested in registering for the company’s conference call can do so using this link.

Inspire Medical Systems (NYSE:INSP) last posted its earnings results on Monday, November 4th. The company reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.54. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. The company had revenue of $203.20 million for the quarter, compared to analyst estimates of $197.59 million. During the same quarter in the prior year, the business posted ($0.29) EPS. The firm’s revenue was up 32.6% compared to the same quarter last year. On average, analysts expect Inspire Medical Systems to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Inspire Medical Systems Stock Down 0.4 %

INSP stock opened at $193.90 on Monday. The stock’s 50 day moving average is $190.21 and its 200-day moving average is $188.66. Inspire Medical Systems has a twelve month low of $123.00 and a twelve month high of $257.40. The firm has a market capitalization of $5.81 billion, a PE ratio of 181.22 and a beta of 1.32.

Analysts Set New Price Targets

INSP has been the topic of a number of recent analyst reports. Piper Sandler reissued an “overweight” rating and set a $260.00 price target (up from $255.00) on shares of Inspire Medical Systems in a research report on Tuesday, November 5th. Stifel Nicolaus dropped their price target on Inspire Medical Systems from $200.00 to $190.00 and set a “hold” rating on the stock in a research report on Tuesday, January 21st. Wells Fargo & Company raised their price objective on shares of Inspire Medical Systems from $187.00 to $198.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 5th. Bank of America raised Inspire Medical Systems from a “neutral” rating to a “buy” rating and lifted their target price for the company from $220.00 to $255.00 in a report on Wednesday, November 20th. Finally, Robert W. Baird boosted their price target on shares of Inspire Medical Systems from $240.00 to $252.00 and gave the company an “outperform” rating in a research report on Tuesday, November 5th. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $231.45.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.